Efficacy and Pharmacokinetics of a Modified acid-labile docetaxel-PRINT ® Nanoparticle Formulation Against non-small-cell Lung Cancer Brain Metastases
- 26 July 2016
- journal article
- research article
- Published by Taylor & Francis in Nanomedicine
- Vol. 11 (15) , 1947-1955
Abstract
Aim: Particle Replication in Nonwetting Templates (PRINT®) PLGA nanoparticles of docetaxel and acid-labile C2-dimethyl-Si-Docetaxel were evaluated with small molecule docetaxel as treatments for non-small-cell lung cancer brain metastases. Materials & methods: Pharmacokinetics, survival, tumor growth and mice weight change were efficacy measures against intracranial A549 tumors in nude mice. Treatments were administered by intravenous injection. Results: Intracranial tumor concentrations of PRINT-docetaxel and PRINT-C2-docetaxel were 13- and sevenfold greater, respectively, than SM-docetaxel. C2-docetaxel conversion to docetaxel was threefold higher in intracranial tumor as compared with nontumor tissues. PRINT-C2-docetaxel increased median survival by 35% with less toxicity as compared with other treatments. Conclusion: The decreased toxicity of the PRINT-C2-docetaxel improved treatment efficacy against non-small-cell lung cancer brain metastasis.Keywords
This publication has 22 references indexed in Scilit:
- Selective Permeabilization of the Blood–Brain Barrier at Sites of MetastasisJNCI: Journal of the National Cancer Institute, 2013
- Pharmacokinetics and Efficacy of PEGylated Liposomal Doxorubicin in an Intracranial Model of Breast CancerPLOS ONE, 2013
- Pharmacokinetics and Antitumor Efficacy of XMT-1001, a Novel, Polymeric Topoisomerase I Inhibitor, in Mice Bearing HT-29 Human Colon Carcinoma XenograftsClinical Cancer Research, 2012
- Incorporation and Controlled Release of Silyl Ether Prodrugs from PRINT NanoparticlesJournal of the American Chemical Society, 2012
- PRINT: A Novel Platform Toward Shape and Size Specific Nanoparticle TheranosticsAccounts of Chemical Research, 2011
- Potent Engineered PLGA Nanoparticles by Virtue of Exceptionally High Chemotherapeutic LoadingsNano Letters, 2011
- Heterogeneous Blood–Tumor Barrier Permeability Determines Drug Efficacy in Experimental Brain Metastases of Breast CancerClinical Cancer Research, 2010
- The effect of particle design on cellular internalization pathwaysProceedings of the National Academy of Sciences, 2008
- Plasma, Tumor, and Tissue Disposition of STEALTH Liposomal CKD-602 (S-CKD602) and Nonliposomal CKD-602 in Mice Bearing A375 Human Melanoma XenograftsClinical Cancer Research, 2007
- Doxorubicin encapsulated in sterically stabilized liposomes for the treatment of a brain tumor model: biodistribution and therapeutic efficacyJournal of Neurosurgery, 1995